306 related articles for article (PubMed ID: 9551997)
1. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis.
Assuma R; Oates T; Cochran D; Amar S; Graves DT
J Immunol; 1998 Jan; 160(1):403-9. PubMed ID: 9551997
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis.
Graves DT; Delima AJ; Assuma R; Amar S; Oates T; Cochran D
J Periodontol; 1998 Dec; 69(12):1419-25. PubMed ID: 9926773
[TBL] [Abstract][Full Text] [Related]
3. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists.
Delima AJ; Karatzas S; Amar S; Graves DT
J Infect Dis; 2002 Aug; 186(4):511-6. PubMed ID: 12195378
[TBL] [Abstract][Full Text] [Related]
4. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.
Delima AJ; Oates T; Assuma R; Schwartz Z; Cochran D; Amar S; Graves DT
J Clin Periodontol; 2001 Mar; 28(3):233-40. PubMed ID: 11284536
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of periodontitis: role of cytokines in host response.
Deo V; Bhongade ML
Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
[TBL] [Abstract][Full Text] [Related]
6. A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice.
Suzuki Y; Aoki K; Saito H; Umeda M; Nitta H; Baron R; Ohya K
J Periodontal Res; 2006 Apr; 41(2):81-91. PubMed ID: 16499710
[TBL] [Abstract][Full Text] [Related]
7. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
8. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.
Graves DT; Cochran D
J Periodontol; 2003 Mar; 74(3):391-401. PubMed ID: 12710761
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis lipopolysaccharide activated bone resorption of osteoclasts by inducing IL-1, TNF, and PGE.
Chen LL; Yan J
Acta Pharmacol Sin; 2001 Jul; 22(7):614-8. PubMed ID: 11749825
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
Bolon B; Campagnuolo G; Zhu L; Duryea D; Zack D; Feige U
Vet Pathol; 2004 May; 41(3):235-43. PubMed ID: 15133172
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis.
Górska R; Gregorek H; Kowalski J; Laskus-Perendyk A; Syczewska M; Madaliński K
J Clin Periodontol; 2003 Dec; 30(12):1046-52. PubMed ID: 15002890
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease.
Kesavalu L; Bakthavatchalu V; Rahman MM; Su J; Raghu B; Dawson D; Fernandes G; Ebersole JL
Oral Microbiol Immunol; 2007 Aug; 22(4):232-9. PubMed ID: 17600534
[TBL] [Abstract][Full Text] [Related]
13. Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis.
Oates TW; Graves DT; Cochran DL
J Clin Periodontol; 2002 Feb; 29(2):137-43. PubMed ID: 11895541
[TBL] [Abstract][Full Text] [Related]
14. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
15. The potential role of chemokines and inflammatory cytokines in periodontal disease progression.
Graves DT
Clin Infect Dis; 1999 Mar; 28(3):482-90. PubMed ID: 10194065
[TBL] [Abstract][Full Text] [Related]
16. Effect of methotrexate on alveolar bone loss in experimental periodontitis in Wistar rats.
Verzeletti GN; Gaio EJ; Rösing CK
Acta Odontol Scand; 2007 Nov; 65(6):348-51. PubMed ID: 18071956
[TBL] [Abstract][Full Text] [Related]
17. [Relationhip between diabetes and periodontal disease].
Nagata T
Clin Calcium; 2009 Sep; 19(9):1291-8. PubMed ID: 19721200
[TBL] [Abstract][Full Text] [Related]
18. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
19. Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models.
Graves DT; Al-Mashat H; Liu R
Compend Contin Educ Dent; 2004 Jul; 25(7 Suppl 1):38-45. PubMed ID: 15645885
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic acetylcholine receptor activation mediates nicotine-induced enhancement of experimental periodontitis.
Breivik T; Gundersen Y; Gjermo P; von Hörsten S; Opstad PK
J Periodontal Res; 2009 Feb; 44(1):110-6. PubMed ID: 18973546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
